Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $232.35 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $151.46 | 5 | $0 (2024) |
| Insulet Corporation | $51.68 | 3 | $0 (2024) |
| Lilly USA, LLC | $16.00 | 1 | $0 (2023) |
| Abbott Laboratories | $13.21 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $118.97 | 6 | Novo Nordisk Inc ($79.50) |
| 2023 | $16.00 | 1 | Lilly USA, LLC ($16.00) |
| 2022 | $12.21 | 1 | Insulet Corporation ($12.21) |
| 2021 | $85.17 | 2 | Novo Nordisk Inc ($71.96) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.36 | General |
| Category: Insulin Pump | ||||||
| 04/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: Insulin Pump | ||||||
| 04/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 10/28/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: Insulin Pump | ||||||
| 08/25/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $71.96 | General |
| Category: Diabetes | ||||||
| 01/20/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 300 | 535 | $80,599 | $27,840 |
| 2022 | 6 | 292 | 547 | $77,197 | $29,979 |
| 2021 | 10 | 353 | 733 | $90,746 | $32,504 |
| 2020 | 5 | 252 | 417 | $58,780 | $20,317 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 310 | $62,620 | $19,553 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 88 | $12,056 | $4,145 | 34.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 47 | $3,525 | $3,377 | 95.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 51 | $663.00 | $649.74 | 98.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 13 | 14 | $560.00 | $59.54 | 10.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 25 | $1,175 | $55.00 | 4.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 308 | $55,132 | $20,880 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 120 | $14,160 | $5,895 | 41.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 36 | 36 | $2,700 | $2,467 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 41 | $533.00 | $522.34 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 19 | $4,028 | $163.80 | 4.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 23 | $644.00 | $51.09 | 7.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 125 | 339 | $60,681 | $22,346 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 109 | $12,862 | $5,747 | 44.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 36 | 36 | $2,685 | $2,344 | 87.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 12 | 19 | $3,572 | $612.94 | 17.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 11 | 21 | $3,969 | $600.87 | 15.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 39 | 39 | $541.00 | $512.78 | 94.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 17 | 19 | $4,028 | $142.50 | 3.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 14 | 102 | $875.00 | $90.42 | 10.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 20 | 26 | $728.00 | $58.50 | 8.0% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2021 | 14 | 23 | $805.00 | $48.69 | 6.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 113 | 248 | $44,392 | $14,187 | 32.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 83 | $9,794 | $3,306 | 33.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 33 | 33 | $1,980 | $1,980 | 100.0% |
About Marsha Collins, PA-C
Marsha Collins, PA-C is a Medical healthcare provider based in Pella, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568458354.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marsha Collins, PA-C has received a total of $232.35 in payments from pharmaceutical and medical device companies, with $118.97 received in 2024. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($232.35).
As a Medicare-enrolled provider, Collins has provided services to 1,197 Medicare beneficiaries, totaling 2,232 services with total Medicare billing of $110,639. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Medical
- Other Specialties Physician Assistant
- Location Pella, IA
- Active Since 09/27/2005
- Last Updated 08/30/2022
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1568458354
Products in Payments
- RYBELSUS (Drug) $71.96
- Omnipod (Device) $51.68
- Ozempic (Drug) $41.21
- Rybelsus (Drug) $38.29
- MOUNJARO (Drug) $16.00
- FreeStyle Libre (Device) $13.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.